[1]
“NATURAL PRODUCT–DRUG INTERACTIONS IN ONCOLOGY: CHEMICAL BASIS, PHARMACEUTICAL CONSIDERATIONS, AND CLINICAL IMPLICATIONS”, Pjmcr, vol. 5, no. 2, pp. 4205–4230, Jun. 2026, doi: 10.66021/pakmcr1500.